The CSG Paradox: Strong Operational Metrics and New Deals Overshadowed by Persistent Bearish Sentiment

Despite a 13.8% revenue jump and €17B order book, CSG's stock slides 16.68% in a week as analyst target cuts and high volatility weigh on sentiment.

The Czechoslovak Group (CSG) finds itself in an uncomfortable position: its operational trajectory points sharply upward, yet its share price continues to slide. The defence contractor reported a 13.8% jump in first-quarter revenue to €1.544 billion and an 8.7% rise in operating profit to €372 million, while its order book swelled from €15 billion to €17 billion. A further €27 billion pipeline of negotiations suggests the growth story is far from over. But on Friday, the stock closed at €15.05, down 3.62% on the day and 16.68% lower than a week earlier.

Two new contracts awarded this week underscore the operational momentum. CSG secured orders for mechanical and electronic fuzes for large-calibre ammunition, worth a high double-digit million euro sum, from European customers within NATO. Deliveries are expected to begin later this year. These fuzes are no minor component — they are critical items in artillery supply chains, directly influencing precision, safety and availability. The deals align with CSG's broader push to secure more munitions production within Europe.

Of greater strategic significance is the planned Fuchs Electronics Europe venture in Slovakia, a joint venture with South Africa’s Reunert. Reunert will hold 51%, CSG 49%. The new entity is designed to become an independent producer of electronic fuzes, supplying not only CSG’s own ammunition lines but also other European manufacturers. Production will take place at ZVS Dubnica nad Váhom, where CSG already has a foothold. The initiative positions CSG among the few makers of electronic fuzes within the European Union, a market that is seeing growing demand as governments seek to reduce reliance on non-EU suppliers.

Yet the market remains unimpressed. The stock now trades roughly 23% below its 50-day moving average of €19.66 and a staggering 58% below the January high of €36.05. The 14-day relative strength index stands at 31.8, inching towards oversold territory but not yet flashing a clear reversal signal. Annualised 30-day volatility has surged to 76.98%, underscoring the violent swings that have characterised the recent price action.

Analyst sentiment has also turned more cautious, albeit with a still-bullish stance. Berenberg’s George McWhirter lowered his price target from €34 to €30, according to Fio banka, while maintaining a “Buy” rating. The reduced target did little to calm frayed nerves, with each minor bounce — like Thursday’s 1.01% uptick in Prague to 381.8 koruna — quickly fading in euro-denominated trading.

On the production front, CSG continues to expand capacity. The company expects to boost its own large-calibre ammunition output to around 850,000 rounds by year-end, up from 550,000 last year, with an additional 400,000 rounds coming from reactivated lines. That represents tangible progress toward meeting the surge in demand from European militaries.

Management has reaffirmed its full-year guidance: revenue between €7.4 billion and €7.6 billion, an operating EBIT margin of roughly 24–25%, investment intensity of about 8.5% of sales, and net working capital below 20% of revenue. Net debt is expected to stay under 1.3 times EBITDA. The next major checkpoint will be half-year results for the period to 30 June 2026, due on 7 August 2026.

For now, the market is suffering from a trust deficit that numbers alone cannot close. CSG is delivering on orders, partnerships and capacity, but investor sentiment remains brittle. Each recovery attempt is being met with selling pressure, leaving the stock to drift lower until the disconnect between operational execution and market perception is resolved.